PJT Partners
PJT
137.61
-2.04
-1.46%
PJT Partners
US · PJT
#2380 by market cap
Listed 1970
137.61
-2.04
-1.46%
Live - 5344 symbols - heartbeat 367s ago
· 2026-10-08 05:11
Pre-market
137.41
-0.15%
After-hours
137.61
0.00%
- Market cap
- 3.52B
- P/E (TTM)i
- 18.75
- P/Bi
- 11.27
- EPSi
- 6.68
- Div yieldi
- 0.73%
- 52W posi
- 15%
Reader sentiment
Are you bullish or bearish on PJT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.96, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +14.77% YoY
Margins
- Gross margin
- 32.43%
- Operating margin
- 21.17%
- Net margin
- 10.51%
Key ratios & quality
- PEG ratioi
- 0.73
- Altman Z-Scorei
- 4.96
PEG uses trailing P/E against the 3-year net income growth rate (25.77%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 580.25M | 717.64M | 1.05B | 991.95M | 1.03B | 1.15B | 1.49B | 1.71B |
| Gross profit | 155.79M | 215.47M | 368.91M | 351.91M | 356.36M | 347.80M | 461.11M | 555.72M |
| Selling & admin expenses | 60.30M | 66.71M | 71.97M | 79.96M | 79.35M | 104.76M | 121.45M | 133.52M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 62.15M | 108.57M | 274.54M | 245.39M | 231.14M | 197.80M | 289.85M | 362.86M |
| Pretax profit | 41.51M | 82.19M | 247.96M | 219.45M | 201.47M | 177.61M | 270.57M | 342.92M |
| Tax | -1.05M | 18.40M | 35.54M | 29.49M | 36.70M | 31.93M | 32.10M | 33.18M |
| Net profit | 42.56M | 63.79M | 212.43M | 189.96M | 164.77M | 145.68M | 238.47M | 309.74M |
| Basic EPS | 1 | 1 | 5 | 4 | 4 | 3 | 5 | 7 |
| Diluted EPS | 0.72 | 1.18 | 4.40 | 3.99 | 3.51 | 3.12 | 4.92 | 6.68 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 324.53M | 406.88M | 447.09M | 535.16M | 418.20M | 486.29M |
| Gross profit | 103.39M | 130.05M | 143.76M | 178.52M | 137.94M | 160.69M |
| Selling & admin expenses | 30.44M | 33.65M | 33.70M | 35.74M | 34.87M | 36.92M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 58.58M | 81.68M | 96.28M | 126.33M | 85.67M | 106.41M |
| Pretax profit | 52.58M | 76.48M | 90.95M | 122.91M | 80.39M | 102.09M |
| Tax | -21.59M | 15.04M | 16.00M | 23.73M | -8.87M | 20.81M |
| Net profit | 74.16M | 61.44M | 74.96M | 99.18M | 89.25M | 81.29M |
| Basic EPS | 2 | 1 | 2 | 2 | 2 | 2 |
| Diluted EPS | 1.99 | 1.21 | 1.47 | 1.97 | 2.21 | 1.66 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 323.88M | 443.47M | 532.68M | 489.75M | 490.99M | 619.07M | 804.66M | 943.18M |
| Cash & ST investments | 106.11M | 215.95M | 299.51M | 200.48M | 173.24M | 355.54M | 483.88M | 538.86M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 671.82M | 952.78M | 1.17B | 987.63M | 1.05B | 1.43B | 1.64B | 1.84B |
| Total current liabilities | 48.01M | 53.09M | 58.01M | 71.32M | 71.55M | 68.81M | 79.92M | 77.94M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | 30.00M | 21.50M | -- | -- | -- | -- | -- | -- |
| Total liabilities | 184,068,000.00 | 378,260,000.00 | 483,761,000.00 | 350,053,000.00 | 291,094,000.00 | 573,814,000.00 | 733,691,000.00 | 834,207,000.00 |
| Total equity | 487.75M | 574.52M | 687.85M | 637.57M | 759.56M | 861.16M | 901.64M | 1.01B |
| Retained earnings | -169.84M | -144.92M | -33.13M | -4.93M | 60.97M | 118.33M | 228.59M | 384.19M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 532.90M | 573.57M | 771.77M | 943.18M | 657.72M | 630.00M |
| Cash & ST investments | 194.27M | 214.62M | 400.45M | 538.86M | 308.78M | 235.54M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.40B | 1.51B | 1.72B | 1.84B | 1.56B | 1.76B |
| Total current liabilities | 89.56M | 91.40M | 78.16M | 77.94M | 80.79M | 92.98M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 572,388,000.00 | 662,796,000.00 | 788,695,000.00 | 834,207,000.00 | 634,056,000.00 | 772,641,000.00 |
| Total equity | 824.31M | 848.60M | 930.44M | 1.01B | 929.72M | 983.17M |
| Retained earnings | 276.35M | 303.16M | 336.91M | 384.19M | 438.16M | 477.57M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 122.94M | 211.26M | 469.44M | 124.16M | 242.73M | 441.53M | 530.95M | 526.30M |
| Depreciation & amortization | 9.97M | 32.81M | 36.36M | 34.93M | 36.21M | 36.66M | 28.67M | 31.25M |
| Free cash flow | 115.73M | 202.45M | 460.59M | 117.69M | 239.30M | 437.61M | 527.65M | 480.44M |
| Dividends paid | -4.32M | -4.65M | -4.82M | -77.97M | -24.63M | -24.44M | -24.13M | -24.52M |
| Stock buybacks / issuance | -64.87M | -47.81M | -48.67M | -103.34M | -109.48M | -116.74M | -235.10M | -195.22M |
| Ending cash balance | 106.11M | 215.95M | 299.51M | 200.48M | 173.24M | 355.54M | 483.88M | 538.86M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -75.94M | 190.43M | 256.10M | 155.71M | 64.25M | 236.96M |
| Depreciation & amortization | 7.54M | 7.81M | 7.86M | 8.03M | 8.68M | 9.16M |
| Free cash flow | -77.92M | 178.91M | 240.90M | 138.55M | 56.00M | 226.38M |
| Dividends paid | -6.26M | -6.09M | -6.09M | -6.09M | -6.53M | -6.42M |
| Stock buybacks / issuance | -127.14M | -63.36M | 0 | -4.72M | -61.28M | -53.24M |
| Ending cash balance | 194.27M | 214.62M | 400.45M | 538.86M | 308.78M | 235.54M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | 126.58 | 77.36 | 59.30 | 38.07 | 62.26 | 72.74 |
| ROA %i | 4.37 | 3.63 | 11.06 | 9.83 | 8.88 | 6.58 | 8.75 | 10.36 |
| ROIC %i | -- | -- | 41.79 | 35.17 | 30.28 | 18.26 | 24.07 | 28.51 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | 299.48 | 72.71 | 61.94 |
| EBIT margin %i | 10.71 | 15.13 | 26.09 | 24.91 | 23.05 | 18.07 | 20.29 | 21.17 |
| FCF / sales %i | 19.95 | 28.23 | 43.78 | 11.86 | 23.33 | 37.95 | 35.34 | 28.04 |
| Current ratioi | 6.75 | 8.35 | 9.18 | 6.87 | 6.86 | 9.00 | 10.07 | 12.10 |
| Quick ratioi | 6.75 | 8.35 | 9.18 | 6.87 | 6.86 | 9.00 | 10.07 | 12.10 |
| Debt / assetsi | 4.47 | 21.46 | 14.71 | 15.90 | 12.91 | 23.04 | 21.68 | 22.46 |
| LT debt / equityi | -- | 651.24 | 111.69 | 130.59 | 73.27 | 135.12 | 189.57 | 134.28 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 12.65 | 12.84 | 28.21 | 19.57 | 12.64 | 3.10 | 14.61 | 18.67 |
| Net income CAGR (3Y) %i | 53.07 | -- | -- | 57.51 | 45.22 | -11.38 | 8.18 | 25.77 |
| FCF CAGR (3Y) %i | 14.92 | 24.96 | 61.10 | 0.56 | 5.73 | -1.69 | 64.89 | 26.15 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 96.33 | 106.47 | 91.85 | 72.74 | 88.53 | 83.23 |
| ROA %i | 11.55 | 10.95 | 10.86 | 10.36 | 12.61 | 12.21 |
| ROIC %i | 29.36 | 30.78 | 30.85 | 28.51 | 29.78 | 30.38 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 20.29 | 20.55 | 21.47 | 21.17 | 21.58 | 21.98 |
| FCF / sales %i | 32.85 | 30.93 | 32.44 | 28.04 | 33.99 | 35.08 |
| Current ratioi | 5.95 | 6.28 | 9.87 | 12.10 | 8.14 | 6.78 |
| Quick ratioi | 5.95 | 6.28 | 9.87 | 12.10 | 8.14 | 6.78 |
| Debt / assetsi | 29.37 | 27.44 | 24.04 | 22.46 | 26.95 | 23.88 |
| LT debt / equityi | 275.65 | 247.65 | 180.77 | 134.28 | 154.55 | 134.38 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Providing advisory services100.00%
Quote time 2026-10-08 05:11:31 · For reference only, not investment advice and not tailored to your situation.